significantly lower – Page 25 – Communicable Diseases Research

A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2

Research

Published on 2022-05-092022-10-05
Journal: Nature metabolism [Category] COVID19(2023년), SARS, 변종, 치료제,

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders

혈액 질환 환자의 SARS-CoV-2 백신 반응 및 돌발성 감염률

Multicenter Study

Published on 2022-05-072022-09-11
Journal: Journal of Hematology & Oncology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] 95% confidence interval Allogeneic stem cell transplantation Analysis antibody Antibody Response Antibody titer Antibody titers Antibody Units Asymptomatic Autologous stem cell transplantation benefit binding antibody unit binding antibody units BNT162b2 Breakthrough infection Breakthrough SARS-CoV-2 infection Cell Cell therapy Clinical efficacy cohort study Complete conducted correlates of protection COVID-19 Cutoff detectable disorder disorders doses Follow-up hematological Hematological malignancies highlight immunization Immunocompromised Immunocompromised patients Immunosuppressed immunosuppressed patient immunosuppressed patients incidence incidence rate Infection Level median Moderna Moderna mRNA-1273 mortality rate Most patient Most patients multicenter multivariate logistic regression multivariate logistic regression analysis Patient Pfizer Pfizer-BioNTech Pfizer-BioNTech BNT162b2 Pneumonia Ratio SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variants severe disease severity significantly lower Spanish stem cell Stem cell transplantation therapy vaccination Vaccine was used
[DOI] 10.1186/s13045-022-01275-7 PMC 바로가기 [Article Type] Multicenter Study

Multisensory mental representation in covid-19 patients and the possibility of long-lasting gustatory and olfactory dysfunction in the CNS

코로나19 환자의 다감각적 정신 표현과 CNS에서 오래 지속되는 미각 및 후각 기능 장애의 가능성

Article

Published on 2022-05-052022-09-11
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 치료기술,

Control of CDH1/E-Cadherin Gene Expression and Release of a Soluble Form of E-Cadherin in SARS-CoV-2 Infected Caco-2 Intestinal Cells: Physiopathological Consequences for the Intestinal Forms of COVID-19

SARS-CoV-2에 감염된 Caco-2 장 세포에서 CDH1/E-Cadherin 유전자 발현 및 가용성 형태의 E-Cadherin 방출 제어: COVID-19의 장 형태에 대한 생리병리학적 결과

Article

Published on 2022-05-042022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 치료기술, 치료제,

[키워드] 24 hour 24 hours 48 hour 48 hours ACE2 ACE2 mRNA Affect AT1 Caco-2 Caco-2 cell Caco-2 cells cadherin CDH1 Cell cell line cells Co-receptor connexin consequence contributing to Control COVID-19 Culture culture supernatant diarrhoea diarrhoea) digestive tract Disruption dissemination down-regulated dysregulation E-cadherin ENCODE epithelial exposure to expresse expression form Gastrointestinal symptom gastrointestinal symptoms gastrointestinal tract HCoV HCoV-OC43 HLA class I human ACE2 illnesses in viral induce infected with SARS-CoV-2 Infection intestinal Intestinal barrier intestinal cells intestinal tissue intranasal involved JAMA junctions leads membrane mRNA mRNA expression OC43 occludin pandemic Patient Physiopathological Post-infection Protein receptor receptor ACE2 Release remained reported respiratory respiratory tract SARS-CoV-2 SARS-COV-2 infection significant increase significantly lower Symptom the disease these symptoms TMPRSS2 Transcription transgenic mice Trigger Viral viral entry virus
[DOI] 10.3389/fcimb.2022.798767 PMC 바로가기 [Article Type] Article

Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies

다양한 유형의 백신 간의 항-RBD SARS-CoV-2 IgG 항체 반응의 효과 및 지속 기간 비교: 백신 전략에 대한 시사점

Article

Published on 2022-05-032022-09-12
Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] Abbott addition anti-RBD Anti-RBD antibody Anti-RBD IgG anti-RBD IgG antibody Antibody Response Antibody titer AstraZeneca Blood Blood Bank Blood bank donors, vaccine booster Booster vaccine Breakthrough infection center CMIA collected COVID-19 COVID-19 vaccines Donor donors Effectiveness Efficacy healthcare worker Healthcare workers highest Hussein IgG IgG level Johnson & Johnson Jordan King material Moderna MOST mRNA vaccine neutralizing antibody participant Pfizer Pfizer/BioNTech Protective random Re-infection recipient Sample SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-CoV-2 vaccines shown significantly significantly lower Sinopharm susceptibility the mean USA vaccination Vaccine vaccine-induced antibody Vaccines were measured
[DOI] 10.1016/j.vaccine.2022.03.069 PMC 바로가기 [Article Type] Article

Evaluation of thorax computed tomographic findings in COVID-19 variant cases

COVID-19 변이 사례에서 흉부 컴퓨터 단층 촬영 결과 평가

Article

Published on 2022-05-012022-09-11
Journal: Respiratory investigation [Category] COVID19(2023년), SARS, 변종,

[키워드] age Alpha Alpha variant average average age Clinical symptoms computed tomographic consolidation COVID-19 COVID-19 pandemic CT finding Diagnosis diagnosis of COVID-19 evaluated feature Follow-up genetic mutation genetic mutations ground glass groups hospital infected with SARS-CoV-2 Laboratory laboratory characteristics laboratory data lower lobe new SARS-CoV-2 no significant difference pandemic Patient patients with COVID-19 PCR testing Peripheral area peripheral areas positive precedence Preliminary Diagnosis RT-PCR RT-PCR testing SARS-CoV-2 variants significant difference significantly lower Swab Thorax thorax CT variant viral replication
[DOI] 10.1016/j.resinv.2021.11.013 PMC 바로가기 [Article Type] Article

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

다발성 골수종 환자에서 SARS-CoV-2 mRNA COVID-19 백신에 대한 낮은 임상 보호 반응

Observational Study

Published on 2022-05-012022-09-12
Journal: International journal of hematology [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] administration age Analysis anti-CD38 Anti-CD38 antibody antibody antibody production Antibody Response Antibody titer Antibody titers B-cell booster CD19+ Cell clinically conducted coronavirus disease COVID-19 COVID-19 vaccine evaluate evaluated healthy controls IgG immunomodulatory drug Japan lymphocyte lymphopenia mRNA mRNA vaccine much lower Multiple Multiple myeloma Patient patients plasma Plasma cell Plasma cell dyscrasia polyclonal Prevalence Protective protocol receiving SARS-CoV-2 Seropositivity significantly higher significantly lower suggested symptomatic therapy vaccination Vaccine vaccine administration
[DOI] 10.1007/s12185-022-03300-4 PMC 바로가기 [Article Type] Observational Study

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England

영국에서 Pfizer 및 AstraZeneca 백신을 사용한 이종 프라임-부스트 COVID-19 백신 접종 일정에 따른 면역 반응에 대한 실제 데이터

Article

Published on 2022-05-012022-09-12
Journal: The Journal of Infection [Category] COVID19(2023년), MERS, SARS, 진단,

Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure

Observational Study

Published on 2022-05-012022-10-04
Journal: Pulmonology [Category] 임상,

[키워드] age Analysis baseline C-reactive protein candidate change Clinical data collected Comorbidity Continuous Continuous positive pressure ventilation coronavirus disease COVID-19 COVID-19 patient CPAP determine fraction Gender increase in intubation Lactate lactate dehydrogenase LDH male multicentre outcome oxygen PaO Patient patients patients treated positive positive airway pressure predictor Predictors of intubation Respiratory failure respiratory rate retrospective ROX index SARS-CoV-2 significantly significantly lower subsequent therapeutic treated Treatment White blood cell white cell
[DOI] 10.1016/j.pulmoe.2020.12.010 PMC 바로가기 [Article Type] Observational Study

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients

벨리무맙 및 리툭시맙 수혜자에서 COVID-19 백신 접종 후 높은 T 세포 반응률

Article

Published on 2022-05-012022-09-11
Journal: Journal of autoimmunity [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,

[키워드] absence All the patient all the patients analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Autoimmune diseases B cell B cells B-cell Belimumab caused circulating comparable completion complex Concentration consecutive patient Control COVID-19 COVID-19 vaccination COVID-19 vaccine detectable anti-SARS-CoV-2 antibodies detectable anti-SARS-CoV-2 antibody diagnostic evaluate evaluated exposure to healthcare personnel immune response immune responses immunogenicity indicate interferon Lupus material median mRNA vaccination mRNA vaccine mRNA vaccines neutralizing capacity Participants Patient patients patients treated positive pseudoviruses RBD receiving recipient recruited retention rituximab RTX SARS-CoV-2 SARS-CoV-2 pseudovirus SARS-CoV-2 pseudoviruses SARS-CoV-2 vaccination significantly lower strain systemic autoimmune disease Systemic autoimmune diseases T cell T-cell Response tested the antibodies the patient therapy Total treated Treatment vaccination Vaccine virus virus-specific cellular immunity
[DOI] 10.1016/j.jaut.2022.102827 PMC 바로가기 [Article Type] Article